Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Pere Soler-Palacin and Jacques Rivière.
Pere Soler-Palacin
Connection Strength
0.683
Jacques Rivière
  1. Tocilizumab in a child with acute lymphoblastic leukaemia and COVID-19-related cytokine release syndrome. An Pediatr (Engl Ed). 2020 Aug; 93(2):132-133.
    View in: PubMed
    Score: 0.223
  2. [Tocilizumab in a child with acute lymphoblastic leukaemia and COVID-19-related cytokine release syndrome]. An Pediatr (Engl Ed). 2020 Aug; 93(2):132-133.
    View in: PubMed
    Score: 0.222
  3. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Sci Immunol. 2021 08 19; 6(62).
    View in: PubMed
    Score: 0.060
  4. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19. Sci Immunol. 2021 08 19; 6(62).
    View in: PubMed
    Score: 0.060
  5. Atypical Inflammatory Syndrome Triggered by SARS-CoV-2 in Infants with Down Syndrome. J Clin Immunol. 2021 10; 41(7):1457-1462.
    View in: PubMed
    Score: 0.059
  6. Multi-inflammatory Syndrome in Children Related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Spain. Clin Infect Dis. 2021 05 04; 72(9):e397-e401.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.